Heart Failure-Induced Brain Injury

Journal of the American College of Cardiology

Volumn 69, Issue 12, 2017, Pages 1609-1616

  Havakuk, Ofer ^a,b   King, Kevin S ^c   Grazette, Luanda ^a   Yoon, Andrew J ^a   Fong, Michael ^a   Bregman, Noa ^b   Elkayam, Uri ^a   Kloner, Robert A ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c Medical Research Institute   (United States)

Author keywords

cerebral blood flow; cognitive impairment; depression

Indexed keywords

ANTICOAGULANT AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BRAIN BLOOD FLOW; BRAIN INJURY; CARDIOCEREBRAL SYNDROME; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEPRESSION; DEVICE THERAPY; HEART DISEASE; HEART FAILURE; HEART PERFORMANCE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEFT VENTRICULAR ASSIST DEVICE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROANATOMY; NEUROENDOCRINE SYSTEM; NEUROLOGIC EXAMINATION; NONHUMAN; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; BRAIN; BRAIN CIRCULATION; BRAIN INJURIES; COGNITIVE DYSFUNCTION; COMPLICATION; PATHOLOGY; PSYCHOLOGY;

BRAIN; BRAIN INJURIES; CEREBROVASCULAR CIRCULATION; COGNITIVE DYSFUNCTION; HEART FAILURE; HUMANS;

EID: 85015654919     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.01.022     Document Type: Review

References (85)

1. 1 Bock, J.S., Gottlieb, S.S., Cardiorenal syndrome: new perspectives. Circulation 121 (2010), 2592–2600.
2. 2 Samsky, M.D., Patel, C.B., DeWald, T.A., et al. Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol 61 (2013), 2397–2405.
3. 3 Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
4. 4 Ferris, E.B. Jr., Objective measurement of relative intracranial blood flow in man: with observations concerning the hydrodynamics of the craniovertebral system. Arch NeurPsych 46 (1941), 377–401.
5. 5 Gruhn, N., Larsen, F.S., Boesgaard, S., et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 32 (2001), 2530–2533.
6. 6 Serrador, J.M., Picot, P.A., Rutt, B.K., et al. MRI measures of middle cerebral artery diameter in conscious humans during simulated orthostasis. Stroke 31 (2000), 1672–1678.
7. 7 Lassen, N.A., Cerebral blood flow and oxygen consumption in man. Physiol Rev 39 (1959), 183–238.
8. 8 Rapela, C.E., Green, H.D., Autoregulation of canine cerebral blood flow. Circ Res 15:Suppl (1964), 205–212.
9. 9 MacKenzie, E.T., Farrar, J.K., Fitch, W., et al. Effects of hemorrhagic hypotension on the cerebral circulation. I. Cerebral blood flow and pial arteriolar caliber. Stroke 10 (1979), 711–718.
10. 10 Symon, L., Held, K., Dorsch, N.W., A study of regional autoregulation in the cerebral circulation to increased perfusion pressure in normocapnia and hypercapnia. Stroke 4 (1973), 139–147.
11. 11 Sercombe, R., Lacombe, P., Aubineau, P., et al. Is there an active mechanism limiting the influence of the sympathetic system on the cerebral vascular bed? Evidence for vasomotor escape from sympathetic stimulation in the rabbit. Brain Res 164 (1979), 81–102.
12. 12 Rajagopalan, B., Raine, A.E., Cooper, R., et al. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment. Am J Med 76 (1984), 86–90.
13. 13 Georgiadis, D., Sievert, M., Cencetti, S., et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J 21 (2000), 407–413.
14. 14 Derdeyn, C.P., Videen, T.O., Yundt, K.D., et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain 125 (2002), 595–607.
15. 15 Lorenzi-Filho, G., Azevedo, E.R., Parker, J.D., et al. Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J 19 (2002), 37–40.
16. 16 Roman, D.D., Kubo, S.H., Ormaza, S., et al. Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol 19 (1997), 692–697.
17. 17 Lanzarone, E., Gelmini, F., Tessari, M., et al. Preservation of endothelium nitric oxide release by pulsatile flow cardiopulmonary bypass when compared with continuous flow. Artif Organs 33 (2009), 926–934.
18. 18 Cornwell, W.K. III, Tarumi, T., Aengevaeren, V.L., et al. Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. J Heart Lung Transplant 33 (2014), 1295–1303.
19. 19 Potapov, E.V., Dranishnikov, N., Morawietz, L., et al. Arterial wall histology in chronic pulsatile-flow and continuous-flow device circulatory support. J Heart Lung Transplant 31 (2012), 1171–1176.
20. 20 Busija, D.W., Heistad, D.D., Marcus, M.L., Effects of sympathetic nerves on cerebral vessels during acute, moderate increases in arterial pressure in dogs and cats. Circ Res 46 (1980), 696–702.
21. 21 Wei, E.P., Raper, A.J., Kontos, H.A., et al. Determinants of response of pial arteries to norepinephrine and sympathetic nerve stimulation. Stroke 6 (1975), 654–658.
22. 22 Markham, D.W., Fu, Q., Palmer, M.D., et al. Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and nonpulsatile left ventricular assist devices. Circ Heart Fail 6 (2013), 293–299.
23. 23 Almeida, O.P., Garrido, G.J., Beer, C., et al. Cognitive and brain changes associated with ischaemic heart disease and heart failure. Eur Heart J 33 (2012), 1769–1776.
24. 24 Vogels, R.L., Scheltens, P., Schroeder-Tanka, J.M., et al. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9 (2007), 440–449.
25. 25 Sauvé, M.J., Lewis, W.R., Blankenbiller, M., et al. Cognitive impairments in chronic heart failure: a case controlled study. J Card Fail 15 (2009), 1–10.
26. 26 Huijts, M., van Oostenbrugge, R.J., Duits, A., et al. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial. Eur J Heart Fail 15 (2013), 699–707.
27. 27 Athilingam, P., D'Aoust, R.F., Miller, L., et al. Cognitive profile in persons with systolic and diastolic heart failure. Congest Heart Fail 19 (2013), 44–50.
28. 28 Cameron, J., Worrall-Carter, L., Page, K., et al. Does cognitive impairment predict poor self-care in patients with heart failure?. Eur J Heart Fail 12 (2010), 508–515.
29. 29 Hawkins, L.A., Kilian, S., Firek, A., et al. Cognitive impairment and medication adherence in outpatients with heart failure. Heart Lung 41 (2012), 572–582.
30. 30 Rutledge, T., Reis, V.A., Linke, S.E., et al. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48 (2006), 1527–1537.
31. 31 Huynh, Q.L., Negishi, K., Blizzard, L., et al. Predictive score for 30-day readmission or death in heart failure. JAMA Cardiol 1 (2016), 362–364.
32. 32 Vogels, R.L., van der Flier, W.M., van Harten, B., et al. Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 9 (2007), 1003–1009.
33. 33 Pan, A., Kumar, R., Macey, P.M., et al. Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure. J Card Fail 19 (2013), 94–100.
34. 34 Román, G.C., Brain hypoperfusion: a critical factor in vascular dementia. Neurol Res 26 (2004), 454–458.
35. 35 Jefferson, A.L., Himali, J.J., Beiser, A.S., et al. Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation 122 (2010), 690–697.
36. 36 Shimizu, A., Sakurai, T., Mitsui, T., et al. Left ventricular diastolic dysfunction is associated with cerebral white matter lesions (leukoaraiosis) in elderly patients without ischemic heart disease and stroke. Geriatr Gerontol Int 14:Suppl 2 (2014), 71–76.
37. 37 van den Hurk, K., Reijmer, Y.D., van den Berg, E., et al. Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail 13 (2011), 1362–1369.
38. 38 Weber, T., Wassertheurer, S., O'Rourke, M.F., et al. Pulsatile hemodynamics in patients with exertional dyspnea: potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction. J Am Coll Cardiol 61 (2013), 1874–1883.
39. 39 Borlaug, B.A., Koepp, K.E., Melenovsky, V., Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction. J Am Coll Cardiol 66 (2015), 1672–1682.
40. 40 Schmidt, R., Fazekas, F., Offenbacher, H., Dusleag, J., Lechner, H., Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy. Stroke 22 (1991), 195–199.
41. 41 Ovbiagele, B., Saver, J.L., Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 22 (2006), 83–90.
42. 42 Newcomer, J.W., Selke, G., Melson, A.K., et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 56 (1999), 527–533.
43. 43 Kirschbaum, C., Wolf, O.T., May, M., et al. Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58 (1996), 1475–1483.
44. 44 Chetty, S., Friedman, A.R., Taravosh-Lahn, K., et al. Stress and glucocorticoids promote oligodendrogenesis in the adult hippocampus. Mol Psychiatry 19 (2014), 1275–1283.
45. 45 Güder, G., Bauersachs, J., Frantz, S., et al. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 115 (2007), 1754–1761.
46. 46 Huffman, J.C., Celano, C.M., Beach, S.R., et al. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol, 2013, 2013, 695925.
47. 47 Cohn, J.N., Levine, T.B., Olivari, M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984), 819–823.
48. 48 Karlamangla, A.S., Singer, B.H., Greendale, G.A., et al. Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging. Psychoneuroendocrinology 30 (2005), 453–460.
49. 49 Gold, P.E., Glucose modulation of memory storage processing. Behav Neural Biol 45 (1986), 342–349.
50. 50 El-Menyar, A.A., Cytokines and myocardial dysfunction: state of the art. J Card Fail 14 (2008), 61–74.
51. 51 Ferketich, A.K., Ferguson, J.P., Binkley, P.F., Depressive symptoms and inflammation among heart failure patients. Am Heart J 150 (2005), 132–136.
52. 52 Parissis, J.T., Adamopoulos, S., Rigas, A., et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 94 (2004), 1326–1328.
53. 53 Reichenberg, A., Yirmiya, R., Schuld, A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58 (2001), 445–452.
54. 54 Wallin, K., Solomon, A., Kåreholt, I., et al. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J Alzheimers Dis 31 (2012), 669–676.
55. 55 Akiyama, H., Barger, S., Barnum, S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000), 383–421.
56. 56 Smith, A.D., Smith, S.M., de Jager, C.A., et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One, 5, 2010, e12244.
57. 57 McAfoose, J., Baune, B.T., Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33 (2009), 355–366.
58. 58 Hanninen, S.A., Darling, P.B., Sole, M.J., et al. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 47 (2006), 354–361.
59. 59 Langlais, P.J., Savage, L.M., Thiamine deficiency in rats produces cognitive and memory deficits on spatial tasks that correlate with tissue loss in diencephalon, cortex and white matter. Behav Brain Res 68 (1995), 75–89.
60. 60 Harper, C., Gold, J., Rodriguez, M., et al. The prevalence of the Wernicke-Korsakoff syndrome in Sydney, Australia: a prospective necropsy study. J Neurol Neurosurg Psychiatry 52 (1989), 282–285.
61. 61 Zuccoli, G., Santa Cruz, D., Bertolini, M., et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol 30 (2009), 171–176.
62. 62 Harper, C., The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain?. J Neuropathol Exp Neurol 57 (1998), 101–110.
63. 63 Saczynski, J.S., Beiser, A., Seshadri, S., et al. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75 (2010), 35–41.
64. 64 Sheline, Y.I., Sanghavi, M., Mintun, M.A., et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19 (1999), 5034–5043.
65. 65 Schiepers, O.J., Wichers, M.C., Maes, M., Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005), 201–217.
66. 66 Bhagwagar, Z., Hafizi, S., Cowen, P.J., Increased salivary cortisol after waking in depression. Psychopharmacology (Berl) 182 (2005), 54–57.
67. 67 Halvorsen, M., Høifødt, R.S., Myrbakk, I.N., et al. Cognitive function in unipolar major depression: a comparison of currently depressed, previously depressed, and never depressed individuals. J Clin Exp Neuropsychol 34 (2012), 782–790.
68. 68 Bermack, J.E., Debonnel, G., The role of sigma receptors in depression. J Pharmacol Sci 97 (2005), 317–336.
69. 69 Skuza, G., Rogóz, Z., Antidepressant-like effect of PRE-084, a selective sigma1 receptor agonist, in Albino Swiss and C57BL/6J mice. Pharmacol Rep 61 (2009), 1179–1183.
70. 70 Ito, K., Hirooka, Y., Matsukawa, R., et al. Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. Cardiovasc Res 93 (2012), 33–40.
71. 71 Weber, P., Vlasicová, Y., Lábrová, R., et al. [Use of creatine phosphate in treatment of cardiocerebral syndrome associated with acute myocardial infarct in the aged]. Cas Lek Cesk 134 (1995), 53–56.
72. 72 Heron, S.E., Hernandez, M., Edwards, C., et al. Neonatal seizures and long QT syndrome: a cardiocerebral channelopathy?. Epilepsia 51 (2010), 293–296.
73. 73 Gulyayev, S.A., The case of cardiocerebral syndrome in a patient with complex heart rhythm disorders. Pharmateca 9 (2012), 76–79.
74. 74 Leto, L., Feola, M., Cognitive impairment in heart failure patients. J Geriatr Cardiol 11 (2014), 316–328.
75. 75 Bhat, G., Yost, G., Mahoney, E., Cognitive function and left ventricular assist device implantation. J Heart Lung Transplant 34 (2015), 1398–1405.
76. 76 Zuccalà, G., Onder, G., Marzetti, E., et al. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 26 (2005), 226–233.
77. 77 Barry, D.I., Paulson, O.B., Jarden, J.O., et al. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats. Am J Med 76 (1984), 79–85.
78. 78 Paulson, O.B., Waldemar, G., Andersen, A.R., et al. Role of angiotensin in autoregulation of cerebral blood flow. Circulation 77 (1988), I55–I58.
79. 79 Laudisio, A., Marzetti, E., Pagano, F., et al. Digoxin and cognitive performance in patients with heart failure: a cohort, pharmacoepidemiological survey. Drugs Aging 26 (2009), 103–112.
80. 80 Vatta, M., Peña, C., Fernández, B.E., Rodríguez de Lores Arnaiz, G., Endobain E, a brain Na+, K+-ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus. Life Sci 76 (2004), 359–365.
81. 81 Reinés, A., Zárate, S., Carmona, C., et al. Endobain E, a brain endogenous factor, is present and modulates NMDA receptor in ischemic conditions. Life Sci 78 (2005), 245–252.
82. 82 Proietti, R., Manzoni, G.M., Cravello, L., et al. Can cardiac resynchronization therapy improve cognitive function? A systematic review. Pacing Clin Electrophysiol 37 (2014), 520–530.
83. 83 Tanne, D., Freimark, D., Poreh, A., et al. Cognitive functions in severe congestive heart failure before and after an exercise training program. Int J Cardiol 103 (2005), 145–149.
84. 84 Karlsson, M.R., Edner, M., Henriksson, P., et al. A nurse-based management program in heart failure patients affects females and persons with cognitive dysfunction most. Patient Educ Couns 58 (2005), 146–153.
85. 85 Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37 (2016), 2129–2200.